Carbimazole丨CAS 22232-54-8

Carbimazole丨CAS 22232-54-8
Product Introduction:
Catalog No.: SS127070
CAS No.: 22232-54-8
Grade/Assay: BP2015/98%~102%
Product Name: Carbimazole
Molecular Formula: C7H10N2O2S
Molecular Weight: 186.23
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of carbimazole丨cas 22232-54-8 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications

 

Appearance: A white or yellow-white crystalline powder
Assay: 98%~102%
Identification: Meet BP2015 standard
Melting Point: 122–125°C
Sulphated Ash: 0.1% max
Impurity A: 0.5% max
Unspecified impurity: 0.1% max
Total impurity: 0.6% max
Solubility: Slightly soluble in water, soluble in acetone and in alcohol
Loss on drying: 0.5% max
Heavy Metals: 10 ppm max
Mesh: 100% should pass through 100#

 

 

 

Applications

 

1. Treatment of Hyperthyroidism

Graves' Disease: Carbimazole is commonly prescribed to control excessive thyroid hormone production in autoimmune hyperthyroidism.

Toxic Multinodular Goiter: Used to manage patients with nodular thyroid disease causing hyperthyroidism.

Preparation for Thyroid Surgery or Radioiodine Therapy: Carbimazole helps normalize thyroid function before definitive treatments.

2. Thyrotoxic Crisis (Thyroid Storm) Management

While not used as a standalone treatment, carbimazole may be administered in combination with beta-blockers and corticosteroids to manage acute thyrotoxicosis, a potentially life-threatening complication of uncontrolled hyperthyroidism.

3. Pediatric Hyperthyroidism

Carbimazole is one of the few antithyroid medications suitable for children and adolescents, due to its efficacy and availability in manageable doses.

 

Benefits

 

 

Prodrug Advantage: Converted to methimazole, which is a more targeted inhibitor of thyroid peroxidase, reducing thyroid hormone production with lower risk of side effects.

Once-Daily Dosing: Long duration of action allows convenient administration, improving patient compliance.

Non-invasive Alternative: Offers a non-surgical and non-radioactive option for patients unsuitable for definitive therapies like thyroidectomy or radioactive iodine.

Good Tolerability: Well-tolerated in most patients when used at appropriate doses and with regular monitoring.

Reversible Effects: Unlike surgery or radioiodine, its effects are reversible, making it a safer first-line treatment, especially for children or during pregnancy.

 

Conclusion

 

Carbimazole (CAS 22232-54-8) is a valuable and effective antithyroid agent widely used in the management of hyperthyroidism. Its role in both short- and long-term treatment plans offers flexibility and safety, especially for patients who are not candidates for surgical or radioactive therapy. As a prodrug of methimazole, it allows for precise thyroid suppression with a manageable side effect profile. With its utility in adult and pediatric care alike, carbimazole continues to be a cornerstone in endocrine therapy for overactive thyroid conditions.

 

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us